See more : Grove Collaborative Holdings, Inc. (GROV-WT) Income Statement Analysis – Financial Results
Complete financial analysis of Tecan Group AG (TCHBF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tecan Group AG, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- NewHold Investment Corp. II (NHICU) Income Statement Analysis – Financial Results
- Montego Resources Inc. (MONGF) Income Statement Analysis – Financial Results
- Bright Green Corporation (BGXX) Income Statement Analysis – Financial Results
- Good Friend International Holdings Inc. (2398.HK) Income Statement Analysis – Financial Results
- Vidli Restaurants Limited (VIDLI.BO) Income Statement Analysis – Financial Results
Tecan Group AG (TCHBF)
About Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.07B | 1.14B | 946.62M | 730.88M | 636.82M |
| Cost of Revenue | 683.92M | 706.19M | 538.05M | 375.96M | 339.55M |
| Gross Profit | 390.47M | 438.07M | 408.57M | 354.92M | 297.27M |
| Gross Profit Ratio | 36.34% | 38.28% | 43.16% | 48.56% | 46.68% |
| Research & Development | 69.74M | 77.89M | 71.87M | 62.04M | 59.86M |
| General & Administrative | 72.05M | 81.42M | 75.47M | 65.98M | 56.65M |
| Selling & Marketing | 119.58M | 132.81M | 120.11M | 105.94M | 92.89M |
| SG&A | 191.63M | 214.23M | 195.57M | 171.93M | 149.54M |
| Other Expenses | -6.87M | 0.00 | 5.00K | 191.00K | 141.00K |
| Operating Expenses | 254.50M | 290.24M | 264.61M | 233.11M | 208.71M |
| Cost & Expenses | 938.42M | 996.43M | 802.67M | 609.07M | 548.26M |
| Interest Income | 4.49M | 383.00K | 31.00K | 32.00K | 23.00K |
| Interest Expense | 1.32M | 1.48M | 4.18M | 1.10M | 1.32M |
| Depreciation & Amortization | 70.79M | 67.05M | 59.04M | 37.72M | 34.06M |
| EBITDA | 205.93M | 211.02M | 201.15M | 157.04M | 118.12M |
| EBITDA Ratio | 19.17% | 18.66% | 21.88% | 20.94% | 19.05% |
| Operating Income | 135.97M | 147.84M | 145.52M | 121.39M | 88.70M |
| Operating Income Ratio | 12.66% | 12.92% | 15.37% | 16.61% | 13.93% |
| Total Other Income/Expenses | -2.16M | -5.35M | -7.59M | -3.16M | -5.96M |
| Income Before Tax | 133.81M | 142.49M | 137.93M | 118.23M | 82.74M |
| Income Before Tax Ratio | 12.45% | 12.45% | 14.57% | 16.18% | 12.99% |
| Income Tax Expense | 1.73M | 21.36M | 16.27M | 14.54M | 9.57M |
| Net Income | 132.07M | 121.13M | 121.66M | 103.69M | 73.17M |
| Net Income Ratio | 12.29% | 10.59% | 12.85% | 14.19% | 11.49% |
| EPS | 10.30 | 9.53 | 9.95 | 8.69 | 6.18 |
| EPS Diluted | 10.30 | 9.47 | 9.88 | 8.62 | 6.13 |
| Weighted Avg Shares Out | 12.82M | 12.72M | 12.23M | 11.93M | 11.84M |
| Weighted Avg Shares Out (Dil) | 12.82M | 12.79M | 12.32M | 12.03M | 11.94M |
Tecan Group AG (TCHBF) Q2 2024 Earnings Call Transcript
Tecan appoints Mukta Acharya Head of the Life Sciences Business division
Tecan Group AG (TCHBF) Q4 2023 Earnings Call Transcript
Tecan Group AG (TCHBF) Q2 2023 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports